SGMOQ SANGAMO THERAPEUTICS, INC: institutional ownership and insider trading
20 funds reported holding $5.80M of SANGAMO THERAPEUTICS, INC in their latest 13F filings; in Q2 2026 funds net sold $5.71M, with 2 new positions and 107 funds selling out; over the last 12 months insiders bought $0 and sold $107K on the open market; over its last four quarters it reported revenue of $34.6M and net income of −$123M.
SGMOQ revenue and earnings
- Quarter ended Mar 31, 2026: revenue $1.44M, net income −$31.0M, EPS -0.08
- Quarter ended Dec 31, 2025: revenue $14.2M, net income −$37.4M, EPS -0.11
- Quarter ended Sep 30, 2025: revenue $581K, net income −$34.9M, EPS -0.11
- Quarter ended Jun 30, 2025: revenue $18.3M, net income −$20.0M, EPS -0.08
Largest institutional holders of SGMOQ
- VANGUARD GROUP INC — $5.04M
- ORACLE INVESTMENT MANAGEMENT INC — $435K
- WOLVERINE TRADING, LLC — $111K
- MERITAGE PORTFOLIO MANAGEMENT — $95.3K
- Cubist Systematic Strategies, LLC — $36.5K
- JANE STREET GROUP, LLC — $32.9K
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. — $22.0K
- VectorGlobal IAG, Inc. — $7.61K
- Sandbox Financial Partners, LLC — $6.13K
- SIMPLEX TRADING, LLC — $4.13K
Recent SGMOQ insider trades
- Apr 22, 2026: Davis Gregory D sold 69,827 shares ($17.5K)
- Apr 21, 2026: Dubois-Stringfellow Nathalie sold 345,942 shares ($89.9K)
5%+ owners
- Armistice Capital, LLC: 9.4% (Schedule 13G/A, filed Aug 14, 2026)
Who owns the most SGMOQ stock?
The largest institutional holders of SANGAMO THERAPEUTICS, INC in the latest 13F filings are VANGUARD GROUP INC ($5.04M), ORACLE INVESTMENT MANAGEMENT INC ($435K), WOLVERINE TRADING, LLC ($111K).
Are insiders buying or selling SGMOQ?
Over the last 12 months insiders bought $0 and sold $107K of SANGAMO THERAPEUTICS, INC stock on the open market (SEC Form 4).
What was SGMOQ's revenue last quarter?
SANGAMO THERAPEUTICS, INC reported revenue of $1.44M for the quarter ended March 31, 2026, with net income of −$31.0M.
Which ETFs hold SGMOQ?
1 ETFs and mutual funds hold it among their top 100 positions, including DLHAX.